LuanP. V. (2023). Blood group B can be a predictor of the EGFR mutations in patients with lung adenocarcinoma. Journal of 108 - Clinical Medicine and Phamarcy, 19(ta). https://doi.org/10.52389/ydls.v19ita.2509